Imunon, Inc.
CLSN
Classement en actions
#34855
Imunon, Inc. is a biotechnology firm in the clinical development stage,... Imunon, Inc. is a biotechnology firm in the clinical development stage, dedicated to innovating and commercializing DNA-centric immunotherapies, vaccines, and targeted chemotherapy solutions. Its primary pipeline assets include GEN-1, a DNA-based immunotherapy specifically designed for the localized treatment of ovarian cancer, and ThermoDox, a unique formulation of doxorubicin encapsulated in heat-activated liposomes, currently being assessed for a variety of cancer indications. Furthermore, the company is advancing two early-phase platform technologies aimed at developing nucleic acid-based immunotherapies, vaccines, and other anti-cancer DNA or RNA treatments. Established in 1982, Imunon, Inc. maintains its operational base in Lawrenceville, New Jersey.
Prix de l'action
$1.96
Dernière synchronisation: 2022-09-20
Capitalisation boursière
$4.46M
Changement (1 jour)
0.00%
Changement (1 an)
122.70%
Pays
US
Échange Imunon, Inc. (CLSN)
Catégorie
Healthcare
Historique du prix de l'action pour Imunon, Inc. (CLSN)
Prix de clôture le plus élevé : $0.93 le 2025-01-01
Prix de clôture le plus bas : $37.95 le 2018-01-01
Prix de clôture le plus bas : $37.95 le 2018-01-01
Historique du prix de l'action de Imunon, Inc. de 2018 à 2026
Performance annuelle du prix de l'action
| Année | Performance |
|---|---|
| 2025 | 10.76% |
| 2024 | -3.79% |
| 2023 | -36.24% |
| 2022 | -86.26% |
| 2021 | -10.52% |
| 2020 | -70.48% |
| 2018 | 0.00% |
Prix de l'action pour des entreprises similaires ou concurrentes
| Entreprise | Prix de l'action | Variation 1a% | Pays |
|---|---|---|---|
| $535.90 | 25.67% |
US
|
|
| $184.77 | 588.14% |
US
|
|
| $137.83 | -3.78% |
AU
|
|
| $291.76 | 2.51% |
BE
|
|
| $881.33 | 8.25% |
NL
|
